Dietary Supplements And FDA: Potential For Partnership?

By David Hoffmeister, Maya Skubatch, Charles Andres, David Van Goor and Indrani Dasgupta (March 7, 2018, 1:15 PM EST) -- On Aug. 18, 2017, dietary supplement ingredient supplier ChromaDex filed a citizen petition requesting that the U.S. Food and Drug Administration "investigate and take appropriate remedial action" against Elysium Health Inc., which markets the dietary supplement Basis. The petition, filed against a backdrop of bicoastal litigation between Elysium and ChromaDex, alleges that samples of Elysium's Basis dietary supplement contained an industrial solvent, toluene, at 94-144 milligrams per kilogram (mg/kg), and also contained lead and molybdenum.[1] The citizen petition and its assertions were surprising and unexpected, especially given Elysium's history and prominence in the dietary supplement industry....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!